Fabrication of TPGS decorated Etravirine loaded lipidic nanocarriers as a neoteric oral bioavailability enhancer for lymphatic targeting
Abstract Etravirine (ERVN) is a potential NNRTI (non-nucleoside reverse transcriptase inhibitor) in treating HIV infection. It possesses extremely low oral bioavailability. The present research aims to optimize the formulation and characterization of TPGS-enriched ERVN-loaded lipid-based nanocarrier...
Main Authors: | Abdul Muheem, Mohd. Wasim, Eman Aldosari, Sanjula Baboota, Javed Ali |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-01-01
|
Series: | Discover Nano |
Subjects: | |
Online Access: | https://doi.org/10.1186/s11671-023-03954-x |
Similar Items
-
A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine
by: Mariana Pereira, et al.
Published: (2023-10-01) -
Facile fabrication of TPGS-PCL polymeric nanoparticles for paclitaxel delivery to breast cancer: investigation of antiproliferation and apoptosis induction
by: Tong Chen, et al.
Published: (2024-12-01) -
Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis
by: Thanh Truong Giang Ly, et al.
Published: (2022-01-01) -
Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening
by: Luis Córdova-Bahena, et al.
Published: (2021-12-01) -
Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects
by: Mariana Pereira, et al.
Published: (2024-03-01)